Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
10,231,356
-
Share change
-
+1,115,170
-
Total reported value
-
$39,596,000
-
Put/Call ratio
-
47%
-
Price per share
-
$3.87
-
Number of holders
-
43
-
Value change
-
+$3,027,966
-
Number of buys
-
18
-
Number of sells
-
17
Institutional Holders of TRACON PHARMACEUTICALS INC - COM NEW (TCON) as of Q3 2021
As of 30 Sep 2021,
TRACON PHARMACEUTICALS INC - COM NEW (TCON) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,231,356 shares.
The largest 10 holders included
Ikarian Capital, LLC, Opaleye Management Inc., Altium Capital Management LP, VANGUARD GROUP INC, TWO SIGMA ADVISERS, LP, NEA Management Company, LLC, TWO SIGMA INVESTMENTS, LP, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., and Linden Advisors LP.
This page lists
43
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.